133 related articles for article (PubMed ID: 31720085)
1. The resistance of esophageal cancer cells to paclitaxel can be reduced by the knockdown of long noncoding RNA DDX11-AS1 through TAF1/TOP2A inhibition.
Zhang S; Jiang H; Xu Z; Jiang Y; She Y; Huang X; Feng S; Chen W; Chen S; Chen Y; Qiu G; Zhong S
Am J Cancer Res; 2019; 9(10):2233-2248. PubMed ID: 31720085
[TBL] [Abstract][Full Text] [Related]
2. MIAT shuttled by tumor-secreted exosomes promotes paclitaxel resistance in esophageal cancer cells by activating the TAF1/SREBF1 axis.
Zhang S; Zhong J; Guo D; Zhang S; Huang G; Chen Y; Xu C; Chen W; Zhang Q; Zhao C; Liu S; Luo Z; Lin C
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23380. PubMed ID: 37132394
[TBL] [Abstract][Full Text] [Related]
3.
Liu J; Yang X; Gao S; Wen M; Yu Q
Pharmacogenomics; 2023 Feb; 24(3):163-172. PubMed ID: 36779347
[No Abstract] [Full Text] [Related]
4. LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer.
Si X; Zhang G; Li M; Yao M; Shi X; Dong Z; Gao S
Pharmacology; 2023; 108(1):61-73. PubMed ID: 36382664
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
Li Y; Zhuang W; Huang M; Li X
Biochem Biophys Res Commun; 2019 Jul; 514(4):1051-1057. PubMed ID: 31097223
[TBL] [Abstract][Full Text] [Related]
6. DDX11-AS1 contributes to osteosarcoma progression via stabilizing DDX11.
Zhang H; Lin J; Chen J; Gu W; Mao Y; Wang H; Zhang Y; Liu W
Life Sci; 2020 Aug; 254():117392. PubMed ID: 32014424
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Value of Long Noncoding RNA DDX11-AS1 as a Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma.
Luo X; Wang Y; Zhang X; Liu W
J Oncol; 2022; 2022():5735462. PubMed ID: 36072974
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA DDX11-AS1 promotes the proliferation and migration of glioma cells by combining with HNRNPC.
Xiang Z; Lv Q; Zhang Y; Chen X; Guo R; Liu S; Peng X
Mol Ther Nucleic Acids; 2022 Jun; 28():601-612. PubMed ID: 35614994
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma.
Zang W; Wang T; Wang Y; Chen X; Du Y; Sun Q; Li M; Dong Z; Zhao G
Oncotarget; 2016 Apr; 7(15):19960-74. PubMed ID: 26799587
[TBL] [Abstract][Full Text] [Related]
10. METTL3-induced FGD5-AS1 contributes to the tumorigenesis and PD-1/PD-L1 checkpoint to enhance the resistance to paclitaxel of endometrial carcinoma.
Hao M; Li T; Xiao L; Liu Y
J Cell Mol Med; 2023 Sep; 28(5):e17971. PubMed ID: 37755125
[TBL] [Abstract][Full Text] [Related]
11. LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel.
Mao BD; Xu P; Xu P; Zhong Y; Ding WW; Meng QZ
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180057
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma.
Lu X; Zhou C; Li R; Deng Y; Zhao L; Zhai W
Cell Physiol Biochem; 2017; 42(1):222-230. PubMed ID: 28535506
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
15. Integrative Analysis of Dysregulated lncRNA-Associated ceRNA Network Reveals Functional lncRNAs in Gastric Cancer.
Liu H; Zhang Z; Wu N; Guo H; Zhang H; Fan D; Nie Y; Liu Y
Genes (Basel); 2018 Jun; 9(6):. PubMed ID: 29912172
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
[TBL] [Abstract][Full Text] [Related]
18. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
Zhou H; Ma Y; Zhong D; Yang L
Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927
[TBL] [Abstract][Full Text] [Related]
20. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
